EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Contact allergy to corticosteroids: Is the European baseline series sufficient?

Sebastian Vigand Svendsen iD, Carsten Bindslev-Jensen iD, Charlotte G Mortz iD

Contact Dermatitis · 2023

DOI: 10.1111/cod.14358 ↗

At a glance

Journal article in Contact Dermatitis, 2023. Written by Sebastian Vigand Svendsen and 2 co-authors. Institution: Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense C, Denmark. Major MEDLINE topics: Dermatitis, Allergic Contact. Cited 4 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Patients are consecutively screened for contact allergy to corticosteroids with budesonide and tixocortol‐21‐pivalate in the European baseline series. Centres using TRUE Test also include hydrocortisone‐17‐butyrate. A supplementary corticosteroid patch test series is used in case of suspicion of corticosteroid contact allergy or when a marker of corticosteroid contact allergy is positive.

Objective

The aims were to evaluate (1) the efficacy of corticosteroids in the TRUE Test and (2) co‐sensitization patterns.

Methods

This retrospective study analysed patients patch tested with TRUE Test corticosteroids plus supplementary corticosteroid series in the period 2006–2020 at the Department of Dermatology and Allergy Centre, Odense University Hospital.

Results

Of 1852 patients tested, 119 were sensitised to TRUE Test corticosteroids and supplementary testing found additional reactions to other corticosteroids in 19 of 119 patients. TRUE Test corticosteroids gave more positive and stronger reactions compared to allergens in petrolatum/ethanol. Fourteen percent of sensitised patients were co‐sensitised to multiple corticosteroid groups. Baeck group 3 corticosteroids accounted for 9 of 16 patients not identified by TRUE Test.

Conclusions

Budesonide, hydrocortisone‐17‐butyrate, and tixocortol‐21‐pivalate in combination are sensitive corticosteroid markers. In case of clinical suspicion of corticosteroid contact allergy, patch testing with supplementary corticosteroids is highly recommended.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactHumansRetrospective StudiesAdrenal Cortex HormonesHydrocortisoneBudesonideAllergensPatch Tests

Author keywords

allergic contact dermatitisallergycontact allergycorticosteroidcorticosteroid contact hypersensitivityhypersensitivity reactionspatch testskin testing

Substances

Adrenal Cortex HormonesHydrocortisoneBudesonideAllergens

Authors and institutions

  • Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense C, Denmark.

ORCID profiles: Sebastian Vigand Svendsen, Carsten Bindslev-Jensen, Charlotte G Mortz

Cite

APA

Svendsen, S. V., Bindslev-Jensen, C., & Mortz, C. G. (2023). Contact allergy to corticosteroids: Is the European baseline series sufficient?. Contact Dermatitis. https://doi.org/10.1111/cod.14358

Vancouver

Svendsen SV, Bindslev-Jensen C, Mortz CG. Contact allergy to corticosteroids: Is the European baseline series sufficient?. Contact Dermatitis. 2023. doi:10.1111/cod.14358

BibTeX
@article{Svendsen2023,
  author = {Svendsen, Sebastian Vigand and Bindslev-Jensen, Carsten and Mortz, Charlotte G},
  title = {Contact allergy to corticosteroids: Is the European baseline series sufficient?},
  journal = {Contact Dermatitis},
  year = {2023},
  doi = {10.1111/cod.14358}
}
Start for free →